Literature DB >> 8050044

Intraventricular insulin increases dopamine transporter mRNA in rat VTA/substantia nigra.

D P Figlewicz1, P Szot, M Chavez, S C Woods, R C Veith.   

Abstract

The hormone insulin can down-regulate the function and synthesis of the re-uptake transporter for norepinephrine (NET) in vivo and in vitro. In the present study we tested whether this action of insulin is generalized to another member of the catecholamine transporter family. We determined the level of dopamine transporter (DAT) mRNA expression in the ventral tegmental area (VTA)/substantia nigra compacta (SNc) of rats which were chronically treated with vehicle or insulin via the third cerebral ventricle (i.c.v.). DAT mRNA was significantly elevated in the VTA/SNc of rats treated with insulin, as compared with levels in vehicle-treated rats. This is in contrast to our previous observation that i.c.v. insulin decreases NET mRNA in the rat locus coeruleus, and suggests that insulin may have differential and specific modulatory effects on CNS catecholaminergic pathways.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8050044     DOI: 10.1016/0006-8993(94)91698-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  46 in total

1.  Human dopamine transporter gene: differential regulation of 18-kb haplotypes.

Authors:  Ying Zhao; Nian Xiong; Yang Liu; Yanhong Zhou; Nuomin Li; Hong Qing; Zhicheng Lin
Journal:  Pharmacogenomics       Date:  2013-09       Impact factor: 2.533

Review 2.  Modulation of food reward by adiposity signals.

Authors:  Dianne P Figlewicz; Amy MacDonald Naleid; Alfred J Sipols
Journal:  Physiol Behav       Date:  2006-11-29

Review 3.  Food reinforcement and eating: a multilevel analysis.

Authors:  Leonard H Epstein; John J Leddy; Jennifer L Temple; Myles S Faith
Journal:  Psychol Bull       Date:  2007-09       Impact factor: 17.737

Review 4.  Endocrine links between food reward and caloric homeostasis.

Authors:  Dianne Figlewicz Lattemann
Journal:  Appetite       Date:  2008-06-26       Impact factor: 3.868

5.  Neuroimaging the interaction of mind and metabolism in humans.

Authors:  Alexandra E D'Agostino; Dana M Small
Journal:  Mol Metab       Date:  2012-08-10       Impact factor: 7.422

Review 6.  Obesity: Current and potential pharmacotherapeutics and targets.

Authors:  Vidya Narayanaswami; Linda P Dwoskin
Journal:  Pharmacol Ther       Date:  2016-10-20       Impact factor: 12.310

7.  High-Fat-Diet-Induced Deficits in Dopamine Terminal Function Are Reversed by Restoring Insulin Signaling.

Authors:  Steve C Fordahl; Sara R Jones
Journal:  ACS Chem Neurosci       Date:  2017-01-03       Impact factor: 4.418

8.  Enhanced cocaine-induced locomotor sensitization and intrinsic excitability of NAc medium spiny neurons in adult but not in adolescent rats susceptible to diet-induced obesity.

Authors:  Max F Oginsky; Joel D Maust; John T Corthell; Carrie R Ferrario
Journal:  Psychopharmacology (Berl)       Date:  2015-11-27       Impact factor: 4.530

9.  Behavioral effects of amphetamine in streptozotocin-treated rats.

Authors:  Rajkumar J Sevak; Wouter Koek; Lynette C Daws; William Anthony Owens; Aurelio Galli; Charles P France
Journal:  Eur J Pharmacol       Date:  2007-11-28       Impact factor: 4.432

10.  Interaction between the obesity-risk gene FTO and the dopamine D2 receptor gene ANKK1/TaqIA on insulin sensitivity.

Authors:  Martin Heni; Stephanie Kullmann; Emma Ahlqvist; Robert Wagner; Fausto Machicao; Harald Staiger; Hans-Ulrich Häring; Peter Almgren; Leif C Groop; Dana M Small; Andreas Fritsche; Hubert Preissl
Journal:  Diabetologia       Date:  2016-09-06       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.